tiprankstipranks
Trending News
More News >
AquaBounty Technologies Inc (AQB)
NASDAQ:AQB

AquaBounty Technologies (AQB) AI Stock Analysis

Compare
1,042 Followers

Top Page

AQB

AquaBounty Technologies

(NASDAQ:AQB)

Select Model
Select Model
Select Model
Neutral 42 (OpenAI - 5.2)
Rating:42Neutral
Price Target:
$0.88
▼(-8.02% Downside)
The score is primarily constrained by very weak financial performance (persistent losses, heavy cash burn, and worsened leverage). Technicals add further pressure with a generally weak trend, while valuation provides limited support because the company is loss-making and no dividend yield is available.
Positive Factors
Sustainable Aquaculture
AquaBounty's emphasis on sustainable aquaculture aligns with growing consumer demand for environmentally friendly products, potentially boosting long-term revenue through partnerships with eco-conscious buyers.
Genetically Engineered Salmon
The unique genetic engineering of AquAdvantage salmon offers a competitive advantage by reducing time to market, enhancing productivity, and potentially increasing market share in the aquaculture industry.
Strong Equity Position
A strong equity position provides financial stability, offering a buffer against operational challenges and supporting potential future investments or expansions.
Negative Factors
Volatile Revenues
Revenue volatility undermines predictability and financial planning, posing risks to long-term growth and operational stability, especially in a competitive market.
Negative Cash Flows
Persistent negative cash flows indicate operational inefficiencies and hinder the company's ability to invest in growth opportunities or weather financial downturns.
Debt-to-Equity Ratio Increase
An increasing debt-to-equity ratio raises concerns about financial leverage, potentially limiting future borrowing capacity and increasing financial risk if cash flows do not improve.

AquaBounty Technologies (AQB) vs. SPDR S&P 500 ETF (SPY)

AquaBounty Technologies Business Overview & Revenue Model

Company DescriptionAquaBounty Technologies, Inc., a biotechnology company, focuses on enhancing productivity in the commercial aquaculture industry in the United States and Canada. The company engages in genetic, genomic, and fish health and nutrition research activities. It offers AquAdvantage Salmon, a bioengineered Atlantic salmon for human consumption; and sells conventional Atlantic salmon, salmon eggs, fry, and byproducts. The company was formerly known as Aqua Bounty Farms, Inc. and changed its name to AquaBounty Technologies, Inc. in June 2004. AquaBounty Technologies, Inc. was incorporated in 1991 and is headquartered in Maynard, Massachusetts.
How the Company Makes MoneyAquaBounty Technologies generates revenue primarily through the sale of its AquAdvantage salmon, which is engineered to reach market size more quickly than conventional salmon. The company operates fish farming facilities where these salmon are raised and harvested for sale. Key revenue streams include direct sales to distributors and retailers in the seafood industry, as well as potential licensing agreements. Partnerships with retailers and seafood distributors play a significant role in expanding the reach of their products to end consumers. Additionally, the company's focus on sustainable and efficient aquaculture practices may attract environmentally conscious buyers and partners, further contributing to its revenue.

AquaBounty Technologies Financial Statement Overview

Summary
AquaBounty Technologies faces significant financial challenges, marked by volatile revenues, persistent losses, and negative cash flows. While there is some stability in its equity position, the company's inability to generate consistent operating and free cash flows poses a significant risk. Improving operational efficiency and cash generation capabilities are critical for future sustainability.
Income Statement
AquaBounty Technologies has experienced significant volatility in its revenue, with the latest period showing a sharp decline to zero. The company has consistently reported negative gross and net profit margins, indicating ongoing challenges in achieving profitability. Despite a positive EBIT and EBITDA in the latest year, this is likely due to extraordinary items rather than operational improvements.
Balance Sheet
The balance sheet shows a strong equity position relative to total assets, which is a positive sign of financial stability. However, the debt-to-equity ratio has increased over time, highlighting a potential risk if the company cannot generate consistent cash flows. The company's leverage is moderate, and liquidity seems adequate with substantial cash reserves.
Cash Flow
Cash flow analysis reveals a concerning trend of negative free cash flows and operating cash flows, indicating that the company is struggling to generate cash from its operations. The negative free cash flow growth rate is alarming, and the operating and free cash flow to net income ratios are unfavorable, reflecting persistent cash management issues.
BreakdownTTMDec 2024Dec 2023Dec 2022Dec 2021Dec 2020
Income Statement
Total Revenue-705.26K0.000.003.14M1.17M127.66K
Gross Profit-705.26K-904.14K-2.16M-10.49M-9.61M-6.55M
EBITDA-52.17M-110.56M-11.45M-19.84M-20.22M-14.75M
Net Income-88.47M-149.19M-27.56M-22.16M-22.32M-16.40M
Balance Sheet
Total Assets24.17M34.06M187.55M213.84M228.44M125.78M
Cash, Cash Equivalents and Short-Term Investments951.43K230.36K8.20M101.66M190.23M95.75M
Total Debt7.94M3.31M5.10M8.90M9.44M9.14M
Total Liabilities11.93M18.22M22.53M21.92M14.63M10.90M
Stockholders Equity12.24M15.84M165.02M191.92M213.80M114.88M
Cash Flow
Free Cash Flow-5.56B-16.79M-93.13M-88.48M-26.19M-18.61M
Operating Cash Flow-5.56B-13.86M-24.24M-21.01M-20.47M-14.29M
Investing Cash Flow7.11B7.56M-68.89M34.35M-107.54M-3.24M
Financing Cash Flow-832.07M-2.66M-308.47K-162.40K121.18M111.00M

AquaBounty Technologies Technical Analysis

Technical Analysis Sentiment
Positive
Last Price0.96
Price Trends
50DMA
0.97
Negative
100DMA
1.24
Negative
200DMA
0.99
Negative
Market Momentum
MACD
-0.02
Negative
RSI
52.26
Neutral
STOCH
36.29
Neutral
Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For AQB, the sentiment is Positive. The current price of 0.96 is above the 20-day moving average (MA) of 0.90, below the 50-day MA of 0.97, and below the 200-day MA of 0.99, indicating a neutral trend. The MACD of -0.02 indicates Negative momentum. The RSI at 52.26 is Neutral, neither overbought nor oversold. The STOCH value of 36.29 is Neutral, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Positive sentiment for AQB.

AquaBounty Technologies Risk Analysis

AquaBounty Technologies disclosed 54 risk factors in its most recent earnings report. AquaBounty Technologies reported the most risks in the "Finance & Corporate" category.
Finance & Corporate - Financial and accounting risks. Risks related to the execution of corporate activity and strategy
Latest Risks Added 0 New Risks

AquaBounty Technologies Peers Comparison

Overall Rating
UnderperformOutperform
Sector (62)
Financial Indicators
Name
Overall Rating
Market Cap
P/E Ratio
ROE
Dividend Yield
Revenue Growth
EPS Growth
62
Neutral
$20.33B14.63-3.31%3.23%1.93%-12.26%
43
Neutral
$50.78M-0.2031.61%37.02%
42
Neutral
$3.73M-0.06
42
Neutral
$3.22M-0.04-179.10%-10.77%97.27%
41
Neutral
$5.75M-0.25-46.64%-29.40%-535.63%
* Consumer Defensive Sector Average
Performance Comparison
Ticker
Company Name
Price
Change
% Change
AQB
AquaBounty Technologies
1.05
0.28
36.36%
SDOT
Sadot Group
3.42
-32.48
-90.47%
AFRI
Forafric Global
10.40
0.54
5.48%
LOCL
Local Bounti Corporation
2.26
0.24
11.93%
EDBL
Edible Garden AG , Inc.
0.84
-5.01
-85.64%

AquaBounty Technologies Corporate Events

Private Placements and Financing
AquaBounty Technologies Secures $4M in Senior Notes
Neutral
Oct 28, 2025

On October 28, 2025, AquaBounty Technologies entered into Note Purchase Agreements with investors for the issuance and sale of $4 million in Senior Notes. These notes are unsecured, nonconvertible, and bear an 18% interest rate, with a maturity date set for 18 months from closing. The agreements include restrictive covenants and events of default, allowing investors certain rights, such as nominating an additional director to the company’s board if defaults occur.

The most recent analyst rating on (AQB) stock is a Hold with a $1.00 price target. To see the full list of analyst forecasts on AquaBounty Technologies stock, see the AQB Stock Forecast page.

Glossary
BuyA stock rated as a "Buy" is expected to perform better than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock is likely to deliver higher returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
HoldA stock rated as a "Hold" is expected to perform in line with the overall market or a specific benchmark. This rating indicates that the stock is neither particularly compelling nor unfavorable for investment. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
SellA stock rated as a "Sell" is expected to perform worse than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock may deliver lower returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.

Disclaimer

This AI Analyst Stock Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in stocks carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.Date of analysis: Dec 30, 2025